Current Treatment Trends in Fabry Disease

被引：0
|
作者：
Linthorst, Gabor [1 ]
机构：
[1] Acad Med Ctr, Dept Endocrinol & Metab, NL-1105 AZ Amsterdam, Netherlands
来源：
CLINICAL THERAPEUTICS | 2009年 / 31卷
关键词：
ENZYME REPLACEMENT THERAPY; HUMAN ALPHA-GALACTOSIDASE; AGALSIDASE-BETA; TRIAL; EFFICACY; SAFETY;
D O I：
10.1016/S0149-2918(09)00245-8
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
引用
收藏
页码：S17 / S18
页数：2
相关论文
共 50 条
  • [41] Outcomes of patients treated through the Canadian Fabry disease initiative
    Sirrs, S. M.
    Bichet, D. G.
    Casey, R.
    Clarke, J. T. R.
    Lemoine, K.
    Doucette, S.
    West, M. L.
    MOLECULAR GENETICS AND METABOLISM, 2014, 111 (04) : 499 - 506
  • [42] Treatment with agalsidase beta during pregnancy in Fabry disease
    Politei, Juan M.
    JOURNAL OF OBSTETRICS AND GYNAECOLOGY RESEARCH, 2010, 36 (02) : 428 - 429
  • [43] Treatment switch in Fabry disease- a matter of dose?
    Lenders, Malte
    Nordbeck, Peter
    Canaan-Kuhl, Sima
    Kreul, Lukas
    Duning, Thomas
    Lorenz, Lora
    Pogoda, Christian
    Brand, Stefan-Martin
    Wanner, Christoph
    Brand, Eva
    JOURNAL OF MEDICAL GENETICS, 2021, 58 (05) : 342 - 350
  • [44] Developments in the treatment of Fabry disease
    van der Veen, Sanne J.
    Hollak, Carla E. M.
    van Kuilenburg, Andre B. P.
    Langeveld, Mirjam
    JOURNAL OF INHERITED METABOLIC DISEASE, 2020, 43 (05) : 908 - 921
  • [45] Treatment of Fabry's Disease with the Pharmacologic Chaperone Migalastat
    Germain, D. P.
    Hughes, D. A.
    Nicholls, K.
    Bichet, D. G.
    Giugliani, R.
    Wilcox, W. R.
    Feliciani, C.
    Shankar, S. P.
    Ezgu, F.
    Amartino, H.
    Bratkovic, D.
    Feldt-Rasmussen, U.
    Nedd, K.
    El Din, U. Sharaf
    Lourenco, C. M.
    Banikazemi, M.
    Charrow, J.
    Dasouki, M.
    Finegold, D.
    Giraldo, P.
    Goker-Alpan, O.
    Longo, N.
    Scott, C. R.
    Torra, R.
    Tuffaha, A.
    Jovanovic, A.
    Waldek, S.
    Packman, S.
    Ludington, E.
    Viereck, C.
    Kirk, J.
    Yu, J.
    Benjamin, E. R.
    Johnson, F.
    Lockhart, D. J.
    Skuban, N.
    Castelli, J.
    Barth, J.
    Barlow, C.
    Schiffmann, R.
    NEW ENGLAND JOURNAL OF MEDICINE, 2016, 375 (06) : 545 - 555
  • [46] Pain in Fabry Disease: Practical Recommendations for Diagnosis and Treatment
    Politei, Juan M.
    Bouhassira, Didier
    Germain, Dominique P.
    Goizet, Cyril
    Guerrero-Sola, Antonio
    Hilz, Max J.
    Hutton, Elspeth J.
    Karaa, Amel
    Liguori, Rocco
    Ueceyler, Nurcan
    Zeltzer, Lonnie K.
    Burlina, Alessandro
    CNS NEUROSCIENCE & THERAPEUTICS, 2016, 22 (07) : 568 - 576
  • [47] A retrospective analysis of the potential impact of IgG antibodies to agalsidase β on efficacy during enzyme replacement therapy for Fabry disease
    Benichou, Bernard
    Goyal, Sunita
    Sung, Crystal
    Norfleet, Andrea M.
    O'Brien, Fanny
    MOLECULAR GENETICS AND METABOLISM, 2009, 96 (01) : 4 - 12
  • [48] Fabry Disease: Current and Novel Therapeutic Strategies. A Narrative Review
    Palaiodimou, Lina
    Kokotis, Panagiotis
    Zompola, Christina
    Papagiannopoulou, Georgia
    Bakola, Eleni
    Papadopoulou, Marianna
    Zouvelou, Vasiliki
    Petras, Dimitrios
    Vlachopoulos, Charalampos
    Tsivgoulis, Georgios
    CURRENT NEUROPHARMACOLOGY, 2023, 21 (03) : 440 - 456
  • [49] Fabry disease: a review of current management strategies
    Mehta, A.
    Beck, M.
    Eyskens, F.
    Feliciani, C.
    Kantola, I.
    Ramaswami, U.
    Rolfs, A.
    Rivera, A.
    Waldek, S.
    Germain, D. P.
    QJM-AN INTERNATIONAL JOURNAL OF MEDICINE, 2010, 103 (09) : 641 - 659
  • [50] Fabry disease - current data and therapeutic approaches
    Dinu, Ilie Robert
    Firu, Stefan George
    ROMANIAN JOURNAL OF MORPHOLOGY AND EMBRYOLOGY, 2021, 62 (01) : 5 - 11
12345